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Short and eﬃcient synthesis of ﬂuorinated
δ-lactams†
Thomas J. Cogswell,a Craig S. Donald,b De-Liang Long‡a and Rodolfo Marquez*§a
The diastereoselective synthesis of ﬂuorinated δ-lactams has been achieved through an eﬃcient ﬁve step
process. The route can tolerate a range of functionalities, and provides a quick route for the generation of
new ﬂuorinated medicinal building blocks.
Introduction
Fluorination has been used to increase the potency and ‘drug-
like’ nature of active compounds for many years, making organo-
fluorine compounds a cornerstone in medicinal chemistry.1
Fluorination has also been extensively used to alter the basicity
of N-heterocycles, and as a tool through which hydrogen
bonding can be probed and assessed.2 As such, new ways to
selectively incorporate fluorine atoms into diﬀerent substruc-
tures is an ever expanding area of research.1,2
δ-Lactams on the other hand are also present widely in
medicinal chemistry and natural systems. For instance, aripi-
prazole 1 is used currently for the treatment of schizophrenia
and bipolar disorders (Fig. 1).3
Thus, it is not surprising that considerable time and
eﬀorts have been directed towards the synthesis of fluorinated
δ-lactams.4–6 However to date, there are a relatively small
number of examples and few general routes available to
enable synthesis of compound libraries to drive structure–activity
relationship understanding in medicinal chemistry programmes.
Herein, we would like to report a short and eﬃcient route
to the synthesis of fluorinated δ-lactams starting from
commercial aldehydes. The methodology is amenable for the
generation of a wide range of δ-lactams, and has the potential
to allow entry into several diﬀerent classes of N-heterocyclic
compounds.
Results and discussion
Our initial studies towards the synthesis of fluorinated
δ-lactams began with benzaldehyde, which upon amino allyla-
tion under Kobayashi conditions aﬀorded amine 3.7 Amide
coupling of amine 3 with 2-fluoroacrylic acid 4 then aﬀorded
the desired diene 5 in 85% yield over the 2 steps (Scheme 1).
Amide 5 was then treated with a range of metathesis
catalysts in an attempt to induce ring closure (Scheme 2),
however only a complex mixture of cross metathesis products
resulted, with no desired cyclised product 6 being detected.
The lack of cyclisation could be attributed to the interaction
of the ruthenium catalyst with the amide group which prevents
Fig. 1 Aripiprazole 1.
Scheme 1 Formation of dialkene 5 from benzaldehyde 2.
Scheme 2 Attempted RCM reaction with dialkene 5.
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the ring closing metathesis from taking place, in a situation
similar to that reported by Vilar and co-workers.8
To test this hypothesis, the route was altered to incorporate a
protecting group on the amide to prevent the amide from inter-
acting with the Ru catalyst. The protecting group of choice was
the p-methoxybenzyl group due to its electron donating pro-
perties, and the ease of removal via oxidative cleavage.9
Thus, reaction of p-methoxybenzylamine with benzaldehyde
yielded the corresponding imine which upon allyl Grignard
addition produced the secondary amine 7a in near quantita-
tive yield. HBTU promoted coupling between the amine 7a and
2-fluoroacrylic acid 4 and then proceeded to generate the
desired amide 8a in good yield.
Gratifyingly, PMB protection of the amide unit allowed the
ring closing metathesis reaction to proceed smoothly to yield
the unsaturated lactam 9a in quantitative yield (Table 1).
With the benzaldehyde example working eﬃciently, the
scope of the methodology was explored (Table 1). Electron
donating and electron withdrawing substituents on the aro-
matic ring were both tested with good results in all cases
through the four step sequence. The electron withdrawing ana-
logue being slightly less eﬃcient in the first three steps,
however, the RCM reaction produced the desired unsaturated
lactam 9c in quantitative yield.
Aliphatic substrates are also well tolerated, and aﬀorded the
corresponding fluorinated lactams 9f, 9g cleanly and in good
yield over the 4 step sequence.
Finally, furan, pyrrole and pyridine frameworks were also
explored due to their widespread use in medicinal and biologi-
cal chemistry. Furfural and N-tosylpyrrole carboxaldehyde pro-
ceeded to generate the structurally interesting fluorinated
δ-lactams 9h, 9i in good yield. In the case of the pyridine unit,
the amino allylation and amide coupling proceeded in reason-
able yields, aﬀording intermediates 7j and 8j respectively.
Unfortunately, the ring closing metathesis failed to generate
the desired fluorinated δ-lactam 9j under any of the conditions
attempted. This was rationalised in the same manner as the
previous example (Scheme 2), where an unprotected nitrogen
atom was thought to bind to the Ru catalyst.
With the fluorinated ring system in place, the removal of
the p-methoxybenzyl protecting group and reduction of the
olefin unit were explored. Removal of the PMB group was
achieved with cerium ammonium nitrate to yield the desired
fluoro-pyridones 10a–g in variable yields (Table 2). Unfortu-
nately, treatment of the furyl and pyrrole substituted pyridones
9h–i with CAN failed to yield the desired unprotected pyri-
dones, resulting instead in substrate decomposition.
Hydrogenation of the fluoro-olefin unit, on the other hand,
proceeded in near quantitative yield in most cases, and with
complete diastereoselectivity to yield the desired fluorinated
δ-lactams 11a–g. The only exception was the brominated ana-
logue 10e, which unsurprisingly yielded the unbrominated
lactam 11a upon hydrogenation in excellent yield.
The syn selectivity of hydrogenation, and hence the stereo-
chemistry of the newly formed C3 stereocentre, is dictated by
the C6 substituent. The relative stereochemistry was corrobo-
rated by X-ray crystallography (Fig. 2).10
The bromo-lactam intermediate 10e, on the other hand,
presented us with an opportunity to further explore the scope
of the fluoro-lactam intermediates as medicinal chemistry
building blocks. Thus treatment of fluoro-lactam 10e under
Suzuki–Miyaura conditions with phenylboronic acid generated
the tricyclic unit 12 in near quantitative yield.11
Alkene reduction under standard conditions then generated
the desired fluoro-lactam unit 13 in excellent yield and with
complete diastereocontrol (Scheme 3).
Table 2 Synthesis of δ-lactams 11a–g
R Yield Yield
Ph 94% 10a 98% 11a
4-MeOPh 40% 10b 83% 11b
4-CF3Ph 47% 10c Quant 11c
Naph 61% 10d Quant 11d
4-BrPh 72% 10e Quant 11e
i-Butyl 97% 10f Quant 11f
Cyclohexyl 79% 10g Quant 11g
Table 1 Synthesis of α,β-unsaturated lactams 9a–i with isolated yields
for the intermediates 7a–j and 8a–j
R Yield Yield Yield
Ph 95% 7a 63% 8a Quant 9a
4-MeOPh 80% 7b 66% 8b Quant 9b
4-CF3Ph 66% 7c 45% 8c Quant 9c
1-Naphthyl 99% 7d 31% 8d Quant 9d
4-BrPh 97% 7e 54% 8e 99% 9e
i-Butyl 76% 7f 74% 8f 85% 9f
Cyclohexyl 74% 7g 70% 8g 89% 9g
2-Furyl 83% 7h 28% 8h 64% 9h
N-Ts 2-pyrrole 85% 7i 50% 8i 77% 9i
2-Pyridyl 73% 7j 68% 8j — 9j
Fig. 2 Crystal structure of ﬂuorinated δ-lactam, 11a.
Scheme 3 Cross-coupling and reduction of α,β-unsaturated lactam
10e to generate δ-lactam 13.
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Conclusions
In conclusion, we have developed a fast and reliable approach
to the synthesis of a number of fluorinated δ-lactams in an
eﬃcient 5 step process. Work is now underway to expand the
methodology to allow access to other fluorinated ring systems
including pyridines and pyrroles as well as developing an
enantioselective variant of this methodology.
Experimental
All reactions were performed in oven-dried glassware under an
inert argon atmosphere unless otherwise stated. Tetrahydro-
furan (THF), diethyl ether, toluene and dichloromethane were
purified through a solvent purification system. Petroleum
ether refers to the fraction boiling between 40 and 60 °C. All
reagents were used as received, unless otherwise stated. Sol-
vents were evaporated under reduced pressure at 40 °C unless
otherwise stated. IR spectra were recorded as thin films on
NaCl plates using a Fourier Transform spectrometer. Only sig-
nificant absorptions (νmax) are reported in wavenumbers
(cm−1). Proton magnetic resonance spectra (1H NMR), fluorine
magnetic resonance spectra (19F NMR) and carbon magnetic
resonance spectra (13C NMR) were recorded at 400 MHz,
377 MHz and 100 MHz or at 500 MHz, 470 MHz and 125 MHz
respectively. 13C NMR spectra were recorded with 1H noise
decoupling. Chemical shifts (δ) are reported in parts per
million (ppm) and are referenced to the residual solvent peak.
The order of citation in parentheses is (1) the number of equi-
valent nuclei (by integration), (2) multiplicity (s = singlet, d =
doublet, t = triplet, q = quartet, quint = quintet, sext = sextet,
sept = septet, m = multiplet, b = broad), (3) and the coupling
constant ( J) quoted in hertz to the nearest 0.1 Hz. High resolu-
tion mass spectra were obtained by electrospray (EI) chemical
ionisation (CI) mass spectrometry operating at a resolution of
15 000 full widths at half height. Flash chromatography was
performed using silica gel (40–63 micron) as the stationary
phase. TLC was performed on aluminium sheets pre-coated
with silica (Silica Gel 60 F254) unless otherwise stated. The
plates were visualised by the quenching of UV fluorescence
(λmax 254 nm) and/or by staining with either anisaldehyde, pot-
assium permanganate, iodine or cerium ammonium molyb-
date followed by heating.
1-Phenylbut-3-en-1-ylamine, 312
Benzaldehyde (0.21 g, 2.0 mmol) was dissolved in methanol
(4 mL) and the resulting solution was cooled to −78 °C. NH3
(ca. 4 mL) was condensed into the solution, and the resulting
reaction mixture was warmed to −10 °C and stirred until the
excess ammonia had evaporated (3 h). Allylboronic pinacol
ester (0.76 mL, 4.0 mmol) was added and the reaction was
stirred for 2 h. The reaction vessel was then allowed to warm
up to room temperature and stirred for a further 1 h. Aq. HCl
(6 M) was added slowly to the solution until pH 1 and the
mixture was extracted with diethyl ether (3 × 20 mL). The
aqueous phase was collected, and aq. NaOH (2 M) was added
slowly until pH 14. The aqueous solution was extracted with
CH2Cl2 (3 × 20 mL). The combined CH2Cl2 phases were then
dried (Na2SO4), filtered and evaporated in vacuo to yield amine
3 as a colourless oil (0.28 g, 1.9 mmol, 95%) which was of
suﬃcient purity to enable the substance to be used without
further purification.
1H (CDCl3, 400 MHz) δ: 7.27–7.15 (5H, m), 5.68–5.63 (1H,
m), 5.06–5.00 (2H, m), 3.91 (1H, dd, JHH = 8.0, 5.2 Hz)
2.40–2.27 (2H, m), 1.60 (2H, br s). 13C (CDCl3, 125 MHz) δ:
145.8, 135.4, 128.4, 127.9, 126.4, 117.7, 55.4, 44.2.
2-Fluoroacrylic acid, 413
Commercially available 2-fluoroacrylic acid methyl ester
(0.87 mL, 9.6 mmol) was dissolved in EtOH–H2O (8.7 : 1.3,
10 mL). Aq. NaOH (2 M) was then added dropwise until pH 11
was reached, and the resulting mixture was stirred for 30 min.
After which, the solution was evaporated to dryness under
vacuum to yield the sodium salt as a white solid. Diethyl ether
(20 mL) was added to the salt, followed by aq. HCl (6 M) drop-
wise until the solid dissolved. The layers were then separated,
and the aqueous layer was extracted with diethyl ether
(10 mL). The organics were combined, dried over sodium
sulfate and evaporated in vacuo to yield the desired acid 4 as a
white solid (0.74 g, 8.0 mmol, 87%) with no need for further
purification.
1H (CDCl3, 400 MHz) δ: 11.51 (1H, br s), 5.92 (1H, dd, JHF =
42.8, JHH = 3.6 Hz), 5.52 (1H, dd, JHF = 12.4, JHH = 3.2 Hz).
19F (CDCl3, 470 MHz) δ: −118.3. 13C (CDCl3, 125 MHz) δ: 165.4
(d, JCF = 46.3 Hz), 151.3 (d, JCF = 323.8 Hz), 105.2 (d, JCF = 18.8 Hz).
2-Fluoro-N-(1-phenyl-but-3-enyl)-propenamide, 5
A solution of 2-fluoroacrylic acid 4 (0.41 g, 4.6 mmol) in
CH2Cl2 (25 mL) was treated with HBTU (2.59 g, 6.5 mmol) and
was then cooled down to 0 °C. DIPEA (1.19 mL, 6.5 mmol) and
amine 3 (0.80 g, 5.4 mmol) were sequentially added, and the
reaction was stirred at room temperature until completion by
TLC analysis (1 h). The solvent was removed under reduced
pressure, and the resulting residue was purified by flash
column chromatography (0–5% EtOAc in petroleum ether)
to yield amide 5 as a white solid (0.89 g, 4.0 mmol, 89%).
m.p. 63–65 °C.
1H (CDCl3, 400 MHz) δ: 7.28–7.16 (5H, m), 6.48 (1H, br s),
5.66–5.55 (2H, m), 5.09–5.03 (4H, m), 2.55 (2H, t, JHH = 6.8 Hz).
19F (CDCl3, 470 MHz) δ: −121.3. 13C (CDCl3, 125 MHz) δ: 158.8
(d, JCF = 30.0 Hz), 156.2 (d, JCF = 268.8 Hz) 140.8, 133.4, 128.8,
127.7, 126.5, 118.3, 99.1 (d, JCF = 15.0 Hz), 52.6, 40.3. m/z
[CI (+ve)] 220.3 [M + H]+, HRMS found [M + H]+ 220.1135,
C13H15FNO requires 220.1138. IR (thin film) νmax = 3338, 1651,
1529, 1190 cm−1.
1-(Toluene-4′-sulfonyl)-1H-pyrrol-2-carboxaldehyde14
Pyrrole-2-carboxyaldehyde (1.00 g, 10.5 mmol) was dissolved in
THF (20 mL) and the solution was cooled down to 0 °C. NaH
(0.62 g, 60% in oil, 15.0 mmol) was added slowly, and the
resulting mixture was stirred at 0 °C for 10 min. Tosyl chloride
Organic & Biomolecular Chemistry Paper
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(3.0 g, 15.0 mmol) was added, and the reaction mixture was
stirred for a further 15 min at 0 °C before being allowed to
warm up to room temperature and stirred overnight. The reac-
tion mixture was quenched with H2O (20 mL), and extracted
with CH2Cl2 (2 × 25 mL). The combined organics were then
dried (Na2SO4) and the solvent was removed in vacuo. The
resulting crude residue was purified by flash column chrom-
atography (0–10% EtOAc in petroleum ether) to yield the tosy-
lated pyrrole as a white solid (2.47 g, 9.9 mmol, 94%).
1H (CDCl3, 400 MHz) δ: 10.01 (1H, s), 7.83 (2H, d, JHH =
8.3 Hz), 7.65 (1H, dd, JHH = 3.0, 1.8 Hz), 7.35 (2H, d, JHH =
8.3 Hz), 7.12 (1H, dd, JHH = 3.7, 1.8 Hz), 6.43 (1H, br appt,
JHH = 3.4 Hz), 2.45 (3H, s).
13C (CDCl3, 125 MHz) δ: 178.9,
145.9, 135.3, 133.6, 130.1, 129.5, 127.6, 124.4, 112.4, 21.7.
General procedure A: synthesis of PMB protected allylic
amines from aldehydes
Na2SO4 (2 g) was dried under vacuum in a round bottom flask
for 10 min. The aldehyde (1 eq.) was then added, followed by
toluene (15 mL) and 4-methoxybenzylamine (1.1 eq.). The
resulting reaction mixture was then heated to reflux for 3 h.
The reaction was then cooled down to room temperature, and
the solid residue was filtered oﬀ. The solution was concen-
trated under vacuum and the residue was re-dissolved in an-
hydrous diethyl ether (20 mL). The solution was placed under
argon and was cooled down to 0 °C. The solution was then
treated dropwise with allylmagnesium bromide (1.5 eq.) and
the resulting mixture was allowed to warm up to room temp-
erature overnight. The reaction was quenched with water
(20 mL) and extracted with diethyl ether (3 × 20 mL). The com-
bined organic extracts were dried over sodium sulfate, and
evaporated under reduced pressure. The crude residue was
purified by flash column chromatography to aﬀord the corres-
ponding allylic amine.
4′-Methoxy-N-(1-phenyl-3-butenyl)benzylamine, 7a15
Following general procedure A, benzaldehyde (0.95 mL,
9.4 mmol) was reacted with 4-methoxybenzylamine (1.4 mL,
10.4 mmol) and allylmagnesium bromide (14.3 mL 1.0 M in
THF, 14.3 mmol). The crude residue was purified by flash
column chromatography (0–2.5% EtOAc in petroleum ether) to
yield the expected amine 7a (2.39 g, 8.9 mmol, 95% yield) as a
pale yellow oil.
1H (CDCl3, 400 MHz) δ: 7.40–7.36 (4H, m,), 7.30–7.28 (1H,
m), 7.20 (2H, d, JHH = 8.6 Hz), 6.88 (2H, d, JHH = 8.6 Hz),
5.75–5.70 (1H, m), 5.11–5.70 (2H, m), 3.83 (3H, s), 3.71
(1H, dd, JHH = 7.8, 5.9 Hz), 3.64 (1H, d, JHH = 13.2 Hz), 3.49
(1H, d, JHH = 13.2 Hz,), 2.44–2.41 (2H, m), 1.73 (1H, br s).
13C (CDCl3, 125 MHz) δ: 158.5, 143.9, 135.5, 132.8, 129.3 (2C),
128.4 (2C), 127.3 (2C), 127.0 (2C), 117.5, 113.7, 61.5, 55.3,
50.8, 43.1.
4′-Methoxy-N-[1-(4″-methoxyphenyl)-3-butenyl]benzylamine, 7b16
Following general procedure A, 4-methoxybenzaldehyde
(0.84 mL, 7.3 mmol) was reacted with 4-methoxybenzylamine
(1.1 mL, 8.0 mmol) and allylmagnesium bromide (11.0 mL
1.0 M in THF, 11.0 mmol). The crude residue was purified
by flash column chromatography (0–5% diethyl ether in
petroleum ether) to yield the expected amine 7b (1.67 g,
5.6 mmol, 77% yield) as a pale yellow oil.
1H (CDCl3, 400 MHz) δ: 7.30 (2H, d, JHH = 8.8 Hz), 7.19 (2H,
d, JHH = 8.6 Hz), 6.92 (2H, d, JHH = 8.8 Hz), 6.87 (2H, d, JHH =
8.6 Hz), 5.75–5.68 (1H, m), 5.12–5.04 (2H, m), 3.85 (3H, s) 3.82
(3H, s), 3.68–3.60 (2H, m), 3.47 (1H, d, JHH = 12.9 Hz),
2.43–2.39 (2H, m). 13C (CDCl3, 125 MHz) δ: 158.6, 158.5, 135.9,
135.6 (2C), 132.8, 129.3 (2C), 128.3 (2C), 117.4, 113.7 (2C),
60.81, 55.3, 55.2, 50.7, 43.2.
4′-Methoxy-N-[1-(4″-trifluoromethanephenyl)-3-butenyl]-
benzylamine, 7c
Following general procedure A, 4-(trifluoromethyl)benz-
aldehyde (0.78 mL, 5.7 mmol) was reacted with 4-methoxyben-
zylamine (0.83 mL, 6.3 mmol) and allylmagnesium bromide
(8.6 mL 1.0 M in THF, 8.6 mmol). The crude product was puri-
fied by flash column chromatography (0–5% diethyl ether
in petroleum ether) to yield the expected amine 7c (1.27 g,
3.8 mmol, 66% yield) as a pale yellow oil.
1H (CDCl3, 400 MHz) δ: 7.62 (2H, d, JHH = 8.2 Hz), 7.51 (2H,
d, JHH = 8.2 Hz), 7.18 (2H, d, JHH = 8.8 Hz), 6.88 (2H, d, JHH =
8.8 Hz), 5.75–5.65 (1H, m), 5.12–5.08 (2H, m), 3.83 (3H, s), 3.77
(1H, dd, JHH = 7.6, 5.6 Hz), 3.64 (1H, d, JHH = 13.2 Hz), 3.45
(1H, d, JHH = 13.2 Hz), 2.45–2.34 (2H, m).
19F (CDCl3, 377 MHz)
δ: −62.3. 13C (CDCl3, 125 MHz) δ: 158.7, 148.2, 134.8, 132.4,
129.8 (2C), 127.7 (2C), 125.7, 125.4 (2C), 125.3, 118.2, 113.8
(2C), 61.2, 55.3, 44.2, 33.6. m/z [CI (+ve)] 336.1 [M + H]+. HRMS
found [M + H]+ 336.1572, C19H21F3NO requires 336.1575.
IR (thin film) νmax = 2935, 1612, 1512, 1323, 1246, 1120,
1066 cm−1.
4′-Methoxy-N-[1-(naphthalen-1″-yl)-3-butenyl]benzylamine, 7d
Following general procedure A, 1-naphthaldehyde (0.86 mL,
6.40 mmol) was reacted with 4-methoxybenzylamine (0.84 mL,
7.0 mmol) and allylmagnesium bromide (9.6 mL 1.0 M in
THF, 9.6 mmol). The crude product was purified by flash
column chromatography (0–10% diethyl ether in petroleum
ether) to yield the desired amine 7d (2.03 g, 6.3 mmol, 99%
yield) as a pale yellow oil.
1H (CDCl3, 400 MHz) δ: 8.10 (1H, appd, JHH = 7.4 Hz),
7.81–7.79 (1H, m), 7.72–7.67 (2H, m), 7.44–7.38 (3H, m), 7.09
(2H, d, JHH = 8.6 Hz), 6.76 (2H, d, JHH = 8.6 Hz), 5.75–5.67 (1H,
m), 5.05–4.97 (2H, m), 3.71 (3H, s), 3.60 (1H, d, JHH = 13.0 Hz),
3.44 (1H, d, JHH = 13.0 Hz), 2.59–2.54 (1H, m), 2.41–2.35 (1H,
m). 13C (CDCl3, 125 MHz) δ: 158.7, 139.7, 138.9, 135.8, 134.1,
132.9, 131.7, 129.4 (2C), 129.0, 127.4, 125.7, 125.3, 123.9,
123.1, 117.7, 113.8 (2C), 56.9, 55.4, 51.1, 42.2. m/z [CI (+ve)]
318.2 [M + H]+, HRMS found [M + H]+ 318.1862, C22H24NO
requires 318.1858. IR (thin film) νmax = 2960, 1511, 1246,
1035 cm−1.
4′-Methoxy-N-[1-(4″-bromophenyl)-3-butenyl]benzylamine, 7e
Following general procedure A, 4-bromobenzaldehyde (1 g,
5.4 mmol) was reacted with 4-methoxybenzylamine (0.74 mL,
Paper Organic & Biomolecular Chemistry
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5.4 mmol) and allylmagnesium bromide (8.1 mL 1.0 M in
THF, 8.1 mmol). The crude product was purified by flash
column chromatography (0–5% diethyl ether in petroleum
ether) to yield the desired amine 7e (1.82 g, 5.25 mmol, 97%
yield) as a pale yellow oil.
1H (CDCl3, 500 MHz) δ: 7.48 (2H, d, JHH = 8.4 Hz), 7.27 (2H,
d, JHH = 8.4 Hz), 7.15 (2H, d, JHH = 9.1 Hz), 6.87 (2H, d, JHH =
9.1 Hz), 5.72–5.63 (1H, m), 5.10–5.05 (2H, m), 3.82 (3H, s), 3.66
(1H, dd, JHH = 7.8, 6.3 Hz), 3.61 (1H, d, JHH = 13.1 Hz), 3.46
(1H, d, JHH = 13.1 Hz), 2.40–2.35 (2H, m).
13C (CDCl3,
125 MHz) δ: 158.7, 143.3, 135.1, 132.6, 131.6 (2C), 129.3 (2C),
129.1 (2C), 120.4, 117.9, 113.9 (2C), 60.7, 55.3, 50.9, 42.7. m/z
[CI (+ve)] 345.8 M+, HRMS found [M + H]+ 346.0804,
C18H21
79BrNO requires 346.0807. IR (thin film) νmax = 2945,
2835, 1511, 1245, 1035, 1009 cm−1.
4′-Methoxy-N-(1-isobutyl-3-butenyl)benzylamine, 7f
Following general procedure A, isovaleraldehyde (1.25 mL,
11.6 mmol) was reacted with 4-methoxybenzylamine (1.7 mL,
12.7 mmol) and allylmagnesium bromide (17.4 mL 1.0 M in
THF, 17.4 mmol). The crude product was purified by flash
column chromatography (0–5% diethyl ether in petroleum ether)
to yield 7f (2.06 g, 8.4 mmol, 76% yield) as a pale yellow oil.
1H (CDCl3, 400 MHz) δ: 7.26 (2H, d, JHH = 8.8 Hz), 6.86 (2H,
d, JHH = 8.8 Hz), 5.82–5.70 (1H, m), 5.14–5.00 (2H, m), 3.81
(3H, s), 3.73 (1H, quint, JHH = 6.4 Hz), 2.70–2.65 (1H, m),
2.25–2.03 (2H, m), 1.62 (1H, appsept, JHH = 6.8 Hz), 1.46–1.23
(2H, m), 0.90 (3H, d, JHH = 6.6 Hz), 0.87 (3H, d, JHH = 6.6 Hz).
13C (CDCl3, 100 MHz) δ: 158.5, 135.8, 133.0, 129.3 (2C), 118.7,
113.7 (2C), 55.3, 54.0, 50.5, 41.2, 38.6, 24.7, 22.5. m/z [CI (+ve)]
248.2 [M + H]+, HRMS found [M + H]+ 248.2018, C16H26NO
requires 248.2014. IR (thin film) νmax = 2953, 2906, 1612, 1512,
1464, 1246 cm−1.
4′-Methoxy-N-(1-cyclohexyl-3-butenyl)benzylamine, 7g
Following general procedure A, cyclohexanecarboxaldehyde
(1.08 mL, 8.87 mmol) was reacted with 4-methoxybenzylamine
(1.2 mL, 9.8 mmol) and allylmagnesium bromide (13.3 mL 1.0
M in THF, 13.3 mmol). The crude product was purified by
flash column chromatography (0–2.5% diethyl ether in pet-
roleum ether) to yield the desired amine 7g (1.81 g, 6.6 mmol,
74% yield) as a pale yellow oil.
1H (CDCl3, 400 MHz) δ: 7.26 (2H, d, JHH = 8.6 Hz), 6.87 (2H,
d, JHH = 8.6 Hz), 5.85–5.75 (1H, m), 5.11–5.06 (2H, m), 3.82
(3H, s), 3.71 (2H, s), 2.42–2.38 (1H, m), 2.32–2.26 (1H, m),
2.16–2.09 (1H, m), 1.81–1.70 (4H, m), 1.47–1.43 (1H, m),
1.31–1.18 (4H, m,), 1.10–1.00 (2H, m). 13C (CDCl3, 125 MHz) δ:
158.5, 136.8, 133.3, 129.3 (2C), 116.8, 113.7 (2C), 61.1, 55.3,
51.3, 40.6, 35.3, 29.4, 28.9, 26.8, 26.7, 26.7. m/z [CI (+ve)] 274.2
[M + H]+, HRMS found [M + H]+ 274.2171, C18H28NO requires
274.2168. IR (thin film) νmax = 2924, 1511, 1246, 1037 cm
−1.
4′-Methoxy-N-[1-(furan-2″-yl)-3-butenyl]benzylamine, 7h
Following general procedure A, 2-furaldehyde (0.86 mL,
10.4 mmol) was reacted with 4-methoxybenzylamine (1.3 mL,
11.4 mmol) and allylmagnesium bromide (15.6 mL 1.0 M in
THF, 15.6 mmol). The crude product was purified by flash
column chromatography (0–5% diethyl ether in petroleum
ether) to yield the desired amine 7h (2.21 g, 8.59 mmol, 83%
yield) as a pale yellow oil.
1H (CDCl3, 400 MHz) δ: 7.42 (1H, dd, JHH = 1.8, 0.8 Hz), 7.23
(2H, d, JHH = 8.7 Hz), 6.88 (2H, d, JHH = 8.7 Hz), 6.36 (1H, dd,
JHH = 3.7, 1.8 Hz), 6.21 (1H, d, JHH = 3.7 Hz), 5.79–5.62 (1H, m),
5.14–5.06 (2H, m), 3.83 (3H, s), 3.79 (1H, t, JHH = 6.8 Hz), 3.72
(1H, d, JHH = 13.0 Hz), 3.56 (1H, d, JHH = 13.0 Hz), 2.58–2.53
(2H, m). 13C (CDCl3, 125 MHz) δ: 158.6, 156.3, 141.5, 134.9,
132.4, 129.4 (2C), 117.5, 113.8 (2C), 109.9, 106.6, 55.3, 54.7,
50.5, 39.3. m/z [CI (+ve)] 258.2 [M + H]+, HRMS found [M + H]+
258.1492, C16H20NO2 requires 258.1494. IR (thin film) νmax =
2930, 2850, 1511, 1441, 1246, 1035 cm−1.
4′-Methoxy-N-[1-(1″-(toluene-4′′′-sulfonyl)-1H-pyrrol-2″-yl)-3-
butenyl]benzylamine, 7i
Following general procedure A, 1-(toluene-4′-sulfonyl)-1H-
pyrrol-2-carboxaldehyde (1 g, 4.02 mmol) was reacted with
4-methoxybenzylamine (0.53 mL, 4.4 mmol) and allylmagne-
sium bromide (6.0 mL 1.0 M in THF, 6.0 mmol). The crude
product was purified by flash column chromatography (0–10%
EtOAc in petroleum ether) to yield the desired amine 7i (1.4 g,
3.42 mmol, 85% yield) as a brown oil.
1H (CDCl3, 500 MHz) δ: 7.62 (2H, d, JHH = 8.3 Hz), 7.36 (1H,
dd, JHH = 3.2, 1.7 Hz), 7.25 (2H, d, JHH = 8.3 Hz), 7.15 (2H, d,
JHH = 8.6 Hz), 6.84 (2H, d, JHH = 8.6 Hz), 6.35–6.33 (1H, m),
6.30 (1H, t, JHH = 3.3 Hz), 5.73–5.63 (1H, m), 5.05–4.98 (2H, m),
4.22 (1H, dd, JHH = 7.3, 5.1 Hz), 3.84 (3H, s), 3.43 (1H, d, JHH =
12.6 Hz), 3.25 (1H, d, JHH = 12.6 Hz), 2.47–2.30 (2H, m), 2.41
(3H, s). 13C (CDCl3, 125 MHz) δ: 158.6, 144.9, 137.6, 136.7,
135.0, 132.6, 129.9 (2C), 129.1 (2C), 126.7 (2C), 123.1, 117.5,
114.1 (2C), 112.7, 111.6, 55.3, 54.0, 50.1, 40.7, 21.7. m/z [ESI]
433.1 [M + Na]+, HRMS found [M + Na]+ 433.1539,
C23H26N2O3SNa requires 433.1556. IR (thin film) νmax = 2975,
1512, 1247, 1172 cm−1.
4′-Methoxy-N-[1-(pyridin-2″-yl)-3-butenyl]benzylamine, 7j
Following general procedure A, pyridine-2-carboxaldehyde
(0.89 mL, 9.30 mmol) was reacted with 4-methoxybenzylamine
(1.2 mL, 10.2 mmol) and allylmagnesium bromide (14.0 mL
1.0 M in THF, 14.0 mmol). The crude product was purified by
flash column chromatography (0–25% diethyl ether in pet-
roleum ether) to yield the desired amine 7j (1.82 g, 6.78 mmol,
73% yield) as a pale yellow oil.
1H (CDCl3, 400 MHz) δ: 8.51 (1H, dq, JHH = 4.8, 0.9 Hz), 7.58
(1H, td, JHH = 7.7, 1.8 Hz), 7.30 (1H, d, JHH = 7.7 Hz), 7.12 (2H,
d, JHH = 8.6 Hz), 7.08 (1H, ddd, JHH = 7.4, 4.8, 1.1 Hz), 6.76 (2H,
d, JHH = 8.6 Hz), 5.70–5.60 (1H, m), 4.99–4.92 (2H, m), 3.75
(1H, dd, JHH = 7.8, 5.9 Hz), 3.71 (3H, s), 3.54 (1H, d, JHH =
12.9 Hz), 3.43 (1H, d, JHH = 12.9 Hz), 2.50–2.43 (1H, m),
2.39–2.32 (1H, m). 13C (CDCl3, 125 MHz) δ: 163.3, 158.5, 149.4,
136.3, 135.3, 132.6, 129.3 (2C), 121.9 (2C), 117.5, 113.7 (2C),
62.8, 55.3, 51.1, 41.6. m/z [CI (+ve)] 269.1 [M + H]+, HRMS
found [M + H]+ 269.1653, C17H21N2O requires 269.1654.
IR (thin film) νmax = 2836, 1512, 1247, 905 cm
−1.
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General procedure B: amide coupling of allylic amine
2-Fluoroacrylic acid (1.5 eq.) and HBTU (1.5 eq.) were dry
mixed and then dissolved in CH2Cl2 (20 mL). DIPEA (1.5 eq.)
was added followed by the corresponding amine (1 eq.). The
resulting solution was stirred and refluxed for 17 h. The reac-
tion was cooled down to room temperature and the solvent
was then evaporated under reduced pressure. The crude
material was purified by flash column chromatography.
2′-Fluoro-N-(4″-methoxybenzyl)-N-(1-phenyl-3-butenyl)-
acrylamide, 8a
Amine 7a (0.5 g, 1.8 mmol) was coupled with 2-fluoroacrylic
acid (0.25 g, 2.8 mmol) using HBTU (1.1 g, 2.8 mmol) follow-
ing general procedure B. The crude product was purified
by flash column chromatography (0–5% diethyl ether in
petroleum ether) to yield the desired dialkene 8a (0.38 g,
1.10 mmol, 63% yield) as a pale yellow oil.
1H (CDCl3, 400 MHz) δ: 7.36–7.32 (5H, m), 6.97 (2H, d,
JHH = 8.6 Hz), 6.76 (2H, d, JHH = 8.3 Hz), 5.75–5.66 (1H, m),
5.35 (1H, br s), 5.26 (1H, br s), 5.08–4.99 (3H, m), 4.47 (1H, d,
JHH = 15.7 Hz), 4.16 (1H, br s), 3.78 (3H, s), 2.74 (2H, br s).
19F (CDCl3, 470 MHz) δ: −102.4, −114.2. 13C (CDCl3, 125 MHz)
δ: 163.3 (d, JCF = 30.0 Hz), 158.7, 158.2 (d, JCF = 271.3), 138.1,
134.2, 134.1 (2C), 129.2 (2C), 128.6 (2C) 128.1 (2C), 118.1,
113.6 (2C), 99.4 (d, JCF = 16.3 Hz), 55.2 (2C), 35.7, 33.5. m/z
[EI (+ve)] 339.2 [M]+, HRMS found [M]+ 339.1639, C21H22FNO2
requires 339.1635. IR (thin film) νmax = 2937, 1637, 1512, 1417,
1246, 1176, 1033 cm−1.
2′-Fluoro-N-(4″-methoxybenzyl)-N-[1-(4′′′-methoxyphenyl)-
3-butenyl]acrylamide, 8b
Amine 7b (0.55 g, 1.8 mmol) was coupled with 2-fluoroacrylic
acid (0.25 g, 2.8 mmol) using HBTU (1.1 g, 2.8 mmol) follow-
ing general procedure B. The crude product was purified
by flash column chromatography (0–5% diethyl ether in
petroleum ether) to yield the desired dialkene 8b (0.44 g,
1.2 mmol, 66%) as a pale yellow oil.
1H (CDCl3, 400 MHz) δ: 7.27 (2H, d, JHH = 8.6 Hz), 6.98 (2H,
d, JHH = 8.6 Hz), 6.89 (2H, d, JHH = 8.4 Hz), 6.77 (2H, d, JHH =
8.4 Hz), 5.74–5.64 (1H, m), 5.35 (1H, br s), 5.23 (1H, br s),
5.07–4.92 (3H, m), 4.46 (1H, d, JHH = 15.5 Hz), 4.14 (1H, br s),
3.83 (3H, s), 3.78 (3H, s), 2.69 (2H, br s). 19F (CDCl3, 470 MHz)
δ: −102.1, −104.2. 13C (CDCl3, 125 MHz) δ: 163.2 (d, JCF = 30.0
Hz), 159.4, 159.3, 158.7, 158.5 (d, JCF = 271.3), 134.2, 134.1,
129.8 (2C), 129.2 (2C), 118.0, 113.9 (2C), 113.6 (2C), 99.2
(d, JCF = 15.0 Hz), 65.9, 55.3, 55.2, 36.04, 33.5. m/z [EI (+ve)]
369.2 [M]+, HRMS found [M]+ 369.1743, C22H24FNO3 requires
369.1740. IR (thin film) νmax = 2933, 2837, 1635, 1512, 1246,
1178, 1033 cm−1.
2′-Fluoro-N-(4″-methoxybenzyl)-N-[1-(4′′′-trifluoromethanephenyl)-
3-butenyl]acrylamide, 8c
Amine 7c (0.64 g, 1.8 mmol) was coupled with 2-fluoroacrylic
acid (0.25 g, 2.8 mmol) using HBTU (1.1 g, 2.8 mmol) follow-
ing general procedure B. The crude product was purified
by flash column chromatography (0–5% diethyl ether in
petroleum ether) to yield the desired dialkene 8c (0.33 g,
0.80 mmol, 45%) as a pale yellow oil.
1H (CDCl3, 400 MHz) δ: 7.57 (2H, d, JHH = 8.0 Hz), 7.44 (2H,
d, JHH = 8.0 Hz), 6.98 (2H, d, JHH = 8.4 Hz), 6.76 (2H, d, JHH =
8.4 Hz), 5.76–5.66 (1H, m), 5.41 (1H, d, JHH = 3.2 Hz), 5.29 (1H,
d, JHH = 3.2 Hz), 5.14–5.09 (3H, m), 4.43 (1H, d, JHH = 15.6 Hz),
4.34 (1H, br. s), 3.80 (3H, s), 2.79 (2H, br. s). 19F (CDCl3,
377 MHz) δ: −62.3, −102.5, −104.4. 13C (CDCl3, 125 MHz) δ:
163.4 (d, JCF = 29.8 Hz), 159.0, 158.0 (d, JCF = 273.0 Hz), 142.5,
139.0, 137.8, 133.9, 129.9, 129.2 (2C), 128.8 (2C), 125.3 (2C),
125.0, 122.9, 118.5, 113.7 (2C), 99.8 (d, JCF = 12.5 Hz), 59.8,
55.2, 35.4. m/z [EI (+ve)] 407.1 [M]+, HRMS found [M]+
407.1504, C22H21F4NO2 requires 407.1508. IR (thin film) νmax =
2939, 1639, 1514, 1415, 1325, 1246, 1120, 1068 cm−1.
2′-Fluoro-N-(4″-methoxybenzyl)-N-[1-(naphthalen-1′′′-yl)-
3-butenyl]acrylamide, 8d
Amine 7d (0.5 g, 1.5 mmol) was coupled with 2-fluoroacrylic
acid (0.21 g, 2.3 mmol) using HBTU (0.89 g, 2.3 mmol) follow-
ing general procedure B. The crude product was purified
by flash column chromatography (0–5% diethyl ether in
petroleum ether) to yield the desired dialkene 8d (0.21 g,
0.53 mmol, 36%) as a pale yellow oil.
1H (CDCl3, 400 MHz) δ: 8.07 (1H, d, JHH = 8.4 Hz), 7.87 (1H,
br d, JHH = 8.4 Hz), 7.82 (1H, t, JHH = 4.6 Hz), 7.59–7.51 (2H,
m), 7.44 (2H, d, JHH = 5.0 Hz), 6.76 (2H, d, JHH = 8.3 Hz), 6.63
(2H, d, JHH = 8.3 Hz), 6.57 (1H, br s), 5.87–5.76 (1H, m), 5.32
(1H, br d, JHF = 47.8 Hz), 5.14–5.05 (3H, m), 4.40 (1H, br d,
JHH = 16.2 Hz), 3.91 (1H, dd, JHH = 16.2, 1.7 Hz), 3.75 (3H, s),
2.77 (2H, appt, JHH = 6.7 Hz).
19F (CDCl3, 377 MHz) δ: −103.7,
−103.8. 13C (CDCl3, 100 MHz) δ: 162.9 (d, JCF = 30.4 Hz), 158.7,
158.2 (d, JCF = 263.3 Hz), 134.7, 133.9, 132.6, 132.5, 129.2,
128.8, 128.6 (2C), 126.9, 126.5, 124.7, 124.6, 123.4, 117.7,
114.4, 113.4 (2C), 99.9 (d, JCF = 15.8 Hz), 55.2 (2C), 54.1, 36.3.
m/z [EI (+ve)] 389.2 [M]+. HRMS found [M]+ 389.1794,
C25H24FNO2 requires 389.1791. IR (thin film) νmax = 2970,
1632, 1513, 1246, 1176 cm−1.
2′-Fluoro-N-(4″-methoxybenzyl)-N-[1-(4′′′-bromophenyl)-
3-butenyl]acrylamide, 8e
Amine 7e (0.50 g, 1.4 mmol) was coupled with 2-fluoroacrylic
acid (0.19 g, 2.2 mmol) using HBTU (0.82 g, 2.2 mmol) follow-
ing general procedure B. The crude product was purified
by flash column chromatography (0–5% diethyl ether in
petroleum ether) to yield the desired dialkene 8e (0.24 g,
0.57 mmol, 41%) as a colourless oil.
1H (CDCl3, 400 MHz) δ: 7.47 (2H, d, JHH = 8.1 Hz), 7.21 (2H,
d, JHH = 8.1 Hz), 6.99 (2H, d, JHH = 8.6 Hz), 6.79 (2H, d, JHH =
8.6 Hz), 5.74–5.63 (1H, m), 5.40–5.25 (2H, m,), 5.19–5.05 (3H,
m), 4.44 (1H, d, JHH = 16.0 Hz), 4.25 (1H, m), 3.81 (3H, s),
2.74–2.69 (2H, m). 19F (CDCl3, 470 MHz) δ: −102.3, −104.2.
13C (CDCl3, 125 MHz) δ: 163.3 (d, JCF = 29.4 Hz), 158.9, 157.9
(d, JCF = 273.3 Hz), 137.3, 133.9, 131.6 (2C), 130.3 (2C), 129.1
(2C), 129.0, 122.0, 118.3, 113. 7 (2C), 99.6 (d, JCF = 15.6 Hz),
55.3 (2C), 35.6, 23.9. m/z [EI (+ve)] 417.0 [M]+, HRMS found
Paper Organic & Biomolecular Chemistry
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[M]+ 417.0739, C21H21
79BrFNO2 requires 417.0740. IR (thin
film) νmax = 2940, 1639, 1513, 1247, 1176 cm
−1.
2′-Fluoro-N-(4″-methoxybenzyl)-N-(1-isobutyl-3-butenyl)-
acrylamide, 8f
Amine 7f (0.27 g, 1.1 mmol) was coupled with 2-fluoroacrylic
acid (0.25 g, 2.8 mmol) using HBTU (1.1 g, 2.8 mmol) follow-
ing general procedure B. The crude product was purified
by flash column chromatography (0–2.5% diethyl ether in
petroleum ether) to yield the desired dialkene 8f (0.26 g,
0.81 mmol, 74%) as a colourless oil.
1H (CDCl3, 400 MHz) δ: 7.27 (2H, d, JHH = 8.0 Hz), 6.85 (2H,
d, JHH = 7.2 Hz), 5.73–5.62 (1H, m), 5.26 (1H, br s), 5.15 (1H,
br s), 5.13–5.02 (2H, m), 4.54–4.39 (2H, m), 4.19–4.01 (1H, m),
3.81 (3H, s), 2.33–2.19 (2H, m), 1.52–1.16 (3H, m), 0.85 (3H, d,
JHH = 6.4 Hz,), 0.74 (3H, d, JHH = 6.0 Hz).
19F (CDCl3, 377 MHz)
δ: −102.4 (dd, JFH = 47.5, 16.2 Hz), −103.6 (dd, JFH = 46.5, 15.1
Hz). 13C (CDCl3, 125 MHz) δ: 163.6 (d, JCF = 30.1 Hz), 158.7,
158.3 (d, JCF = 270.0 Hz), 135.4, 134.3, 130.3, 129.2 (2C), 118.0,
113.8 (2C), 98.5, 57.2, 55.3, 44.1, 42.0, 38.9, 24.6, 22.7. m/z
[CI (+ve)] 320.2 [M + H]+, HRMS found [M + H]+ 320.2025,
C19H27FNO2 requires 320.2026. IR (thin film) νmax = 2958,
1637, 1514, 1246 cm−1.
2′-Fluoro-N-(4″-methoxybenzyl)-N-(1-cyclohexyl-3-butenyl)-
acrylamide, 8g
Amine 7g (0.48 g, 1.8 mmol) was coupled with 2-fluoroacrylic
acid (0.24 g, 2.6 mmol) using HBTU (1.0 g, 2.6 mmol) follow-
ing general procedure B. The crude product was purified
by flash column chromatography (0–2.5% diethyl ether in pet-
roleum ether) to yield the desired dialkene 8g (0.44 g,
1.3 mmol, 70%) as a colourless oil.
1H (CDCl3, 400 MHz) δ: 7.32 (2H, d, JHH = 8.6 Hz), 6.84
(2H, d, JHH = 8.6 Hz), 5.63–5.56 (1H, m), 5.27–4.91 (4H, m),
4.43 (2H, s), 3.81 (3H, s), 3.69 (1H, br t, JHH = 9.3 Hz),
2.51–2.44 (1H, m), 2.33–2.25 (1H, m), 1.85–1.51 (5H, m),
1.20–1.05 (2H, m), 0.97–0.81 (4H, m). 19F (CDCl3, 470 MHz) δ:
−102.7. 13C (CDCl3, 125 MHz) δ: 164.6 (d, JCF = 30.0 Hz), 158.7,
158.2 (d, JCF = 270.0 Hz), 134.6, 130.1, 129.8 (2C), 117.7, 113.7
(2C), 98.5 (d, JCF = 15.0 Hz), 64.7, 55.3, 44.8, 40.9, 35.1, 30.5,
30.4, 26.3, 26.1, 26.0. m/z [CI (+ve)] 346.3 [M + H]+, HRMS
found [M + H]+ 346.2176, C21H29FNO2 requires 346.2182. IR
(thin film) νmax = 2924, 2852, 1635, 1513, 1442, 1246 cm
−1.
2′-Fluoro-N-(4″-methoxybenzyl)-N-[1-(furan-2′′′-yl)-3-butenyl]-
acrylamide, 8h
Amine 7h (0.5 g, 1.9 mmol) was coupled with 2-fluoroacrylic
acid (0.26 g, 2.9 mmol) using HBTU (1.1 g, 2.9 mmol) follow-
ing general procedure B. The crude product was purified
by flash column chromatography (0–10% diethyl ether in
petroleum ether) to yield the desired dialkene 8h (0.18 g,
0.54 mmol, 28%) as a yellow oil.
1H (CDCl3, 400 MHz) δ: 7.36 (1H, br s), 7.00 (2H, d, JHH =
8.6 Hz), 6.77 (2H, d, JHH = 8.6 Hz), 6.35–6.25 (2H, m), 5.72–5.64
(1H, m), 5.38–5.24 (2H, m), 5.10–5.05 (3H, m), 4.55 (1H, d,
JHH = 15.7 Hz), 4.27 (1H, m), 3.80 (3H, s), 2.65–2.59 (2H, m).
19F (CDCl3, 470 MHz) δ: −103.5, −105.3. 13C (CDCl3, 125 MHz)
δ: 163.1 (d, JCF = 29.4 Hz), 158.6, 157.6 (d, JCF = 267.8 Hz),
151.9, 142.4, 133.1, 129.2 (2C), 118.7, 114.2, 113.6 (2C), 110.3,
109.2, 99.3, 57.7, 55.2, 44.4, 23.8. m/z [EI (+ve)] 329.2 [M]+,
HRMS found [M]+ 329.1427, C19H20FNO3 requires 329.1428. IR
(thin film) νmax = 2956, 1699, 1513, 1246, 1117 cm
−1.
2′-Fluoro-N-(4″-methoxybenzyl)-N-[1-(1′′′-(toluene-4′′′′-sulfonyl)-
1H-pyrrol-2′′′-yl)-3-butenyl]acrylamide, 8i
Amine 7i (0.66 g, 1.6 mmol) was coupled with 2-fluoroacrylic
acid (0.22 g, 2.4 mmol) using HBTU (0.92 g, 2.4 mmol) follow-
ing general procedure B. The crude product was purified
by flash column chromatography (0–15% EtOAc in petroleum
ether) to yield the desired dialkene 8i (0.39 g, 0.81 mmol, 50%)
as a pale yellow oil.
1H (CDCl3, 400 MHz) δ: 7.72 (2H, br s), 7.39 (1H, br s), 7.31
(2H, d, JHH = 8.3 Hz), 7.00 (2H, d, JHH = 8.6 Hz), 6.81 (2H, d,
JHH = 8.6 Hz), 6.26–6.12 (2H, m), 5.75–5.65 (1H, m), 5.50–5.08
(3H, m), 4.81–4.53 (3H, m), 4.09 (1H, d, JHH = 6.0 Hz), 3.81
(3H, s), 2.49–2.41 (5H, m). 19F (CDCl3, 470 MHz) δ: −103.9.
13C (CDCl3, 125 MHz) δ: 162.4 (d, JCF = 29.4 Hz), 159.3, 157.9
(d, JCF = 276.8 Hz), 145.2, 143.4, 137.0, 135.9, 133.8, 130.0 (2C),
129.7 (2C), 129.3, 127.2 (2C), 117.8, 117.4, 114.0, 113.5 (2C),
98.9, 60.4, 55.2, 51.8, 46.7, 21.6. m/z [EI (+ve)] 482.1 [M]+,
HRMS found [M]+ 482.1676, C26H27FN2O2S requires 482.1676.
IR (thin film) νmax = 2975, 1652, 1511, 1247 cm
−1.
2′-Fluoro-N-(4″-methoxybenzyl)-N-[1-(pyridin-2′′′-yl)-3-butenyl]-
acrylamide, 8j
Amine 7j (0.5 g, 1.86 mmol) was coupled with 2-fluoroacrylic
acid (0.25 g, 2.8 mmol) using HBTU (1.1 g, 2.8 mmol) follow-
ing general procedure B. The crude product was purified
by flash column chromatography (0–25% diethyl ether in
petroleum ether) to yield the desired dialkene 8j (0.42 g,
1.24 mmol, 67%) as a pale yellow oil.
1H (CDCl3, 400 MHz) δ: 8.55 (1H, s), 7.63 (1H, dt, JHH = 7.7,
1.8 Hz), 7.37 (1H, br s), 7.19 (1H, br s), 6.93 (2H, d, JHH =
8.6 Hz), 6.70 (2H, d, JHH = 8.6 Hz), 5.76–5.65 (1H, m), 5.47–5.02
(5H, m), 4.59 (2H, s), 3.76 (3H, s), 3.04–2.95 (1H, m), 2.89–2.80
(1H, m). 19F (CDCl3, 377 MHz) δ: −102.5, −105.1. 13C (CDCl3,
125 MHz) δ: 163.4 (d, JCF = 29.4 Hz), 158.5, 158.0 (d, JCF = 271.5
Hz), 157.7, 149.0, 136.6, 134.4, 129.7 (2C), 128.7, 124.1, 122.9,
118.3, 113.5 (2C), 99.5 (d, JCF = 16.5 Hz), 62.5, 59.5, 55.1, 35.0.
m/z [CI (+ve)] 341.1 [M + H]+, HRMS found [M + H]+ 341.1669,
C20H22FN2O2 requires 341.1665. IR (thin film) νmax = 1638,
1513, 1415, 1207, 1176 cm−1.
General procedure C: ring-closing metathesis of fluorinated
dialkene
A solution of the dialkene (1 eq.) in toluene (0.0025 g ml−1)
was treated with Grubbs 2nd generation catalyst (2.5 mol%)
and the resulting mixture was heated to 100 °C until com-
pletion as indicated by TLC analysis (1–4 hours). The reaction
was cooled down to room temperature, the solvent was
removed under reduced pressure and the crude material was
purified by flash column chromatography.
Organic & Biomolecular Chemistry Paper
This journal is © The Royal Society of Chemistry 2015 Org. Biomol. Chem., 2015, 13, 717–728 | 723
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
9 
A
ug
us
t 2
01
4.
 D
ow
nl
oa
de
d 
on
 0
2/
04
/2
01
5 
11
:5
0:
19
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
3-Fluoro-1-(4′-methoxybenzyl)-6-phenyl-5, 6-dihydro-1H-
pyridin-2-one, 9a
Dialkene 8a (0.11 g, 0.32 mmol) was subjected to general
procedure C. The crude product was purified by flash column
chromatography (0–10% EtOAc in petroleum ether) to yield the
desired α,β-unsaturated lactam 9a (0.10 g, 0.32 mmol, quanti-
tative yield) as a colourless oil.
1H (CDCl3, 400 MHz) δ: 7.40–7.34 (3H, m), 7.19 (2H, d,
JHH = 7.2 Hz), 7.15 (2H, d, JHH = 8.6 Hz), 6.86 (2H, d, JHH =
8.6 Hz), 5.77 (1H, m), 5.54 (1H, d, JHH = 14.8 Hz), 4.57 (1H, dd,
JHH = 7.7, 2.6 Hz), 3.83 (3H, s), 3.51 (1H, d, JHH = 14.8 Hz),
2.99–2.93 (1H, m), 2.50–2.44 (1H, m). 19F (CDCl3, 470 MHz) δ:
−126.8. 13C (CDCl3, 125 MHz) δ: 159.8 (d, JCF = 30.0 Hz), 159.2,
149.4 (d, JCF = 251.1 Hz), 139.4, 129.6 (2C), 129.0, 128.9 (2C),
128.0, 126.4 (2C), 114.1 (2C), 109.5 (d, JCF = 14.6 Hz), 57.0,
55.3, 47.2, 29.4 (d, JCF = 6.0 Hz). m/z [EI (+ve)] 311.2 [M]
+.
HRMS found [M]+ 311.1318, C19H18FNO2 requires 311.1322. IR
(thin film) νmax = 2933, 2837, 1651, 1512, 1247, 1176, 1031 cm
−1.
3-Fluoro-1-(4′-methoxybenzyl)-6-(4″-methoxyphenyl)-5,6-
dihydro-1H-pyridin-2-one, 9b
Dialkene 8b (0.22 g, 0.58 mmol) was subjected to general
procedure C. The crude product was purified by flash column
chromatography (0–10% EtOAc in petroleum ether) to yield the
desired α,β-unsaturated lactam 9b (0.19 g, 0.58 mmol, quanti-
tative yield) as a colourless oil.
1H (CDCl3, 400 MHz) δ: 7.05 (2H, d, JHH = 8.8 Hz), 7.00 (2H,
d, JHH = 8.8 Hz), 6.80 (2H, d, JHH = 8.8 Hz), 6.77 (2H, d, JHH =
8.8 Hz), 5.70–5.66 (1H, m), 5.66 (1H, d, JHH = 14.8 Hz), 4.41
(1H, dd, JHH = 7.6, 3.2 Hz), 3.74 (3H, s), 3.84 (3H, s), 3.39 (1H,
d, JHH = 14.8 Hz), 2.84–2.79 (1H, m), 2.37–2.32 (1H, m).
19F (CDCl3, 470 MHz) δ: −126.7. 13C (CDCl3, 125 MHz) δ: 159.7
(d, JCF = 30.2 Hz), 159.4, 159.2, 149.4 (d, JCF = 252.5 Hz), 131.2,
129.6 (2C), 129.0, 127.6 (2C), 114.2 (2C), 114.1 (2C), 109.6
(d, JCF = 13.8 Hz), 56.6, 55.4, 55.3, 47.1, 29.6 (d, JCF = 5.0 Hz).
m/z [EI (+ve)] 341.1 [M]+. HRMS found [M]+ 341.1420,
C20H20FNO3 requires 341.1427. IR (thin film) νmax = 2951,
2837, 1651, 1512, 1462, 1247, 1178, 1033 cm−1.
3-Fluoro-1-(4′-methoxybenzyl)-6-(4″-trifluoromethanephenyl)-
5,6-dihydro-1H-pyridin-2-one, 9c
Dialkene 8c (0.20 g, 0.49 mmol) was subjected to general
procedure C. The crude product was purified by flash column
chromatography (0–10% EtOAc in petroleum ether) to yield the
desired α,β-unsaturated lactam 9c (0.18 g, 0.49 mmol, quanti-
tative yield) as a colourless oil.
1H (CDCl3, 400 MHz) δ: 7.64 (2H, d, JHH = 8.0 Hz), 7.30 (2H,
d, JHH = 8.4 Hz), 7.14 (2H, d, JHH = 8.6 Hz), 6.85 (2H, d, JHH =
8.6 Hz), 5.78–5.75 (1H, m), 5.52 (1H, d, JHH = 14.8 Hz), 4.62
(1H, dd, JHH = 7.6, 2.0 Hz), 3.82 (3H, s), 3.53 (1H, d, JHH =
14.8 Hz), 3.05–2.98 (1H, m), 2.48–2.43 (1H, m). 19F (CDCl3,
470 MHz) δ: −62.3, −126.1. 13C (CDCl3, 125 MHz) δ: 159.6
(d, JCF = 30.1 Hz), 159.4, 149.4 (d, JCF = 253.8 Hz), 143.5, 130.6,
130.3, 129.6 (2C), 128.5, 126.8 (2C), 124.9 (2C), 114.2 (2C),
109.3 (d, JCF = 15.0 Hz), 56.7, 55.3, 47.5, 29.2 (d, JCF = 6.3 Hz).
m/z [EI (+ve)] 379.0 [M]+, HRMS found [M]+ 379.1198,
C20H17F4NO2 requires 379.1195. IR (thin film) νmax = 2970,
1737, 1654, 1512, 1413, 1327, 1249, 1112, 1068 cm−1.
3-Fluoro-1-(4′-methoxybenzyl)-6-(naphthalen-1″-yl)-5,6-dihydro-
1H-pyridin-2-one, 9d
Dialkene 8d (0.14 g, 0.36 mmol) was subjected to general pro-
cedure C. The crude product was purified by flash column
chromatography (0–15% EtOAc in petroleum ether) to yield the
desired α,β-unsaturated lactam 9d (0.13 g, 0.36 mmol, quanti-
tative yield) as a colourless oil.
1H (CDCl3, 400 MHz) δ: 7.97–7.94 (1H, m), 7.88 (1H, d,
JHH = 8.2 Hz), 7.78–7.75 (1H, m), 7.56–7.53 (2H, m), 7.49 (1H,
br t, JHH = 7.7 Hz), 7.34 (1H, d, JHH = 7.2 Hz), 7.15 (2H, d, JHH =
8.5 Hz), 6.86 (2H, d, JHH = 8.5 Hz), 5.74–7.69 (1H, m), 5.61 (1H,
d, JHH = 14.8 Hz), 5.39 (1H, br d, JHH = 8.3 Hz), 3.83 (3H, s),
3.47 (1H, d, JHH = 14.8 Hz), 3.12–3.04 (1H, m), 2.70–2.62 (1H,
m). 19F (CDCl3, 377 MHz) δ: −127.5. 13C (CDCl3, 125 MHz) δ:
160.5 (d, JCF = 31.2 Hz), 159.2, 149.1 (d, JCF = 255.0 Hz), 134.4,
133.5, 130.2, 129.7, 129.5 (2C), 129.1, 128.8, 126.7, 125.8,
125.3, 123.9 121.9, 114.1 (2C), 109.9 (d, JCF = 14.7 Hz), 55.3,
53.7, 47.4, 27.8 (d, JCF = 5.5 Hz). m/z [EI (+ve)] 361.2 [M]
+.
HRMS found [M]+ 361.1480, C23H20FNO2 requires 361.1478.
IR (thin film) νmax = 2932, 1652, 1511, 1244, 1200 cm
−1.
3-Fluoro-1-(4′-methoxybenzyl)-6-(4″-bromophenyl)-5,6-dihydro-
1H-pyridin-2-one, 9e
Dialkene 8e (0.17 g, 0.41 mmol) was subjected to general
procedure C. The crude product was purified by flash column
chromatography (0–15% EtOAc in petroleum ether) to yield the
desired α,β-unsaturated lactam 9e (0.15 g, 0.39 mmol, 96%) as
a colourless oil.
1H (CDCl3, 400 MHz) δ: 7.51 (2H, d, JHH = 8.5 Hz), 7.14 (2H,
d, JHH = 8.6 Hz), 7.05 (2H, d, JHH = 8.5 Hz), 6.87 (2H, d, JHH =
8.6 Hz), 5.79–5.74 (1H, m), 5.50 (1H, d, JHH = 14.6 Hz), 4.52
(1H, dd, JHH = 7.6, 2.4 Hz), 3.83 (3H, s), 3.51 (1H, d, JHH =
14.6 Hz), 3.00–2.91 (1H, m), 2.46–2.38 (1H, m). 19F (CDCl3,
377 MHz) δ: −126.3. 13C (CDCl3, 100 MHz) δ: 159.6 (d, JCF =
31.0 Hz), 159.3, 149.3 (d, JCF = 253.0 Hz), 138.5, 132.1 (2C),
129.6 (2C) 128.6, 128.1 (2C), 122.0, 114.2 (2C), 109.4 (d, JCF =
15.0 Hz), 56.5, 55.3, 47.3, 29.3 (d, JCF = 6.0 Hz). m/z [CI (+ve)]
391.7 [M + H]+, HRMS found [M + H]+ 390.0489,
C19H18
79BrFNO2 requires 390.0505. IR (thin film) νmax = 2950,
1653, 1512, 1247, 1217 cm−1.
3-Fluoro-1-(4′-methoxybenzyl)-6-isobutyl-5, 6-dihydro-
1H-pyridin-2-one, 9f
Dialkene 8f (0.23 g, 0.71 mmol) was subjected to general
procedure C. The crude product was purified by flash column
chromatography (0–10% EtOAc in petroleum ether) to yield the
desired α,β-unsaturated lactam 9f (0.17 g, 0.60 mmol, 85%) as
a pale yellow oil.
1H (CDCl3, 400 MHz) δ: 7.14 (2H, d, JHH = 8.4 Hz), 6.79 (2H,
d, JHH = 8.8 Hz), 5.77–5.71 (1H, m), 5.27 (1H, d, JHH = 14.8 Hz),
3.73 (3H, s), 3.66 (1H, d, JHH = 14.8 Hz), 3.31–3.26 (1H, m),
2.48–2.44 (1H, m), 2.14–2.07 (1H, m), 1.72–1.65 (1H, m),
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1.43–1.39 (1H, m), 1.27–1.17 (1H, m), 0.85 (3H, d, JHH =
6.8 Hz), 0.76 (3H, d, JHH = 6.8 Hz).
19F (CDCl3, 470 MHz) δ:
−127.6. 13C (CDCl3, 125 MHz) δ: 159.2, 158.7 (d, JCF = 31.3 Hz),
149.6 (d, JCF = 252.5 Hz), 129.5, 129.4 (2C), 114.1 (2C), 109.8
(d, JCF = 13.8 Hz), 55.3, 52.1, 46.9, 39.6, 25.1, 24.6 (d, JCF =
5.0 Hz), 23.6, 21.5. m/z [EI (+ve)] 291.2 [M]+. HRMS found [M]+
291.1629, C17H22FNO2 requires 291.1635. IR (thin film) νmax =
2955, 1651, 1512, 1249, 1201 cm−1.
3-Fluoro-1-(4′-methoxybenzyl)-6-cyclohexane-5, 6-dihydro-
1H-pyridin-2-one, 9g
Dialkene 8g (0.35 g, 1.06 mmol) was subjected to general
procedure C. The crude product was purified by flash column
chromatography (0–10% EtOAc in petroleum ether) to yield the
desired α,β-unsaturated lactam 9g (0.30 g, 0.94 mmol, 89%) as
a colourless oil.
1H (CDCl3, 400 MHz) δ: 7.23 (2H, d, JHH = 8.8 Hz), 6.87 (2H,
d, JHH = 8.8 Hz), 5.83–5.79 (1H, m), 5.49 (1H, d, JHH = 14.9 Hz),
3.83 (3H, s), 3.79 (1H, d, JHH = 14.9 Hz), 3.18 (1H, br t, JHH =
6.8 Hz), 2.54–2.45 (1H, m), 2.36–2.28 (1H, m), 1.86–1.63 (6H,
m), 1.29–1.07 (4H, m), 1.00–0.94 (1H, m). 19F (CDCl3,
470 MHz) δ: −128.2. 13C (CDCl3, 125 MHz) δ: 159.2, 159.0
(d, JCF = 31.1 Hz), 149.5 (d, JCF = 253.2 Hz, CF), 129.7, 129.3
(2C), 114.1 (2C), 110.6 (d, JCF = 14.2 Hz), 59.0, 55.3, 48.7, 40.8,
30.3, 30.2, 26.4, 26.3, 26.2, 22.8 (d, JCF = 5.5 Hz). m/z [CI (+ve)]
318.2 [M + H]+, HRMS found [M + H]+ 318.1871, C19H25FNO2
requires 318.1869. IR (thin film) νmax = 2925, 2850, 1645, 1511,
1247, 1198 cm−1.
3-Fluoro-1-(4′-methoxybenzyl)-6-(furan-2″-yl)-5,6-dihydro-
1H-pyridin-2-one, 9h
Dialkene 8h (0.37 g, 1.1 mmol) was subjected to general
procedure C. The crude product was purified by flash column
chromatography (0–10% EtOAc in petroleum ether) to yield the
desired α,β-unsaturated lactam 9h (0.21 g, 0.69 mmol, 62%) as
a colourless oil.
1H (CDCl3, 400 MHz) δ: 7.40 (1H, dd, JHH = 1.7, 0.6 Hz), 7.22
(2H, d, JHH = 8.6 Hz), 6.90 (2H, d, JHH = 8.6 Hz), 6.36 (1H, dd,
JHH = 3.2, 1.8 Hz), 6.19 (1H, br d, JHH = 3.2 Hz), 5.91–5.86 (1H,
m), 5.48 (1H, d, JHH = 14.8 Hz), 4.59 (1H, dd, JHH = 7.0, 2.5 Hz),
3.84 (3H, s), 3.75 (1H, d, JHH = 14.8 Hz), 2.84–2.75 (1H, m),
2.67–2.59 (1H, m). 19F (CDCl3, 470 MHz) δ: −126.3. 13C (CDCl3,
125 MHz) δ: 159.4 (d, JCF = 30.0 Hz), 152.2, 149.1 (d, JCF = 252.5
Hz), 142.5, 131.0, 129.6 (2C), 128.9, 114.2 (2C), 110.3, 110.1
(d, JCF = 16.5 Hz), 107.5, 55.3, 51.6, 47.4, 26.2 (d, JCF = 5.9 Hz).
m/z [EI (+ve)] 301.2 [M]+. HRMS found [M]+ 301.1111,
C17H16FNO3 requires 301.1114. IR (thin film) νmax = 2957,
2364, 1654, 1513, 1415, 1248, 1117 cm−1.
3-Fluoro-1-(4′-methoxybenzyl)-6-(1″-(toluene-4′′′-sulfonyl)-
1H-pyrrol-2″-yl)-5,6-dihydro-1H-pyridin-2-one, 9i
Dialkene 8i (0.23 g, 0.47 mmol) was subjected to general
procedure C. The crude product was purified by flash column
chromatography (0–30% EtOAc in petroleum ether) to yield the
desired α,β-unsaturated lactam 9i (0.16 g, 0.36 mmol, 77%) as
a pale yellow oil.
1H (CDCl3, 400 MHz) δ: 7.50 (2H, d, JHH = 8.5 Hz), 7.37
(1H, dd, JHH = 1.7, 1.5 Hz), 7.30 (2H, d, JHH = 8.5 Hz), 6.89 (2H,
d, JHH = 8.6 Hz), 6.83 (2H, d, JHH = 8.6 Hz), 6.28 (1H, t, JHH =
3.3 Hz), 6.16–6.15 (1H, m), 5.76–5.72 (1H, m), 5.30 (1H, d,
JHH = 15.0 Hz), 4.95 (1H, d, JHH = 7.2 Hz), 3.85 (3H, s), 3.12 (1H,
d, JHH = 15.0 Hz), 2.94–2.87 (1H, m), 2.71–2.65 (1H, m), 2.47
(3H, s). 19F (CDCl3, 377 MHz) δ: −127.9. 13C (CDCl3, 125 MHz)
δ: 159.6 (d, JCF = 30.0 Hz), 159.1, 148.8 (d, JCF = 252.5 Hz),
145.4, 136.1, 132.5, 130.3 (2C), 128.9 (2C), 128.8, 126.4 (2C),
124.8, 114.8, 114.0 (2C), 112.0, 109.8 (d, JCF = 15.0 Hz), 55.3,
51.9, 47.4, 27.0 (d, JCF = 6.3 Hz), 21.7. m/z [ESI (+ve)] 477.1
[M + Na]+, HRMS found [M + Na]+ 477.1259, C24H23FN2O4SNa
requires 477.1255. IR (thin film) νmax = 2955, 1630, 1515, 1447,
1276, 1205 cm−1.
General procedure D: removal of the p-methoxybenzyl
protecting group
The cyclic amide (1 eq.) was dissolved in a MeCN–H2O (8 : 2,
4 mL) mixture and ceric ammonium nitrate was added por-
tionwise. The resulting solution was stirred at room tempera-
ture until completion indicated by TLC analysis (7 h). The
reaction was quenched with aq. sat. NaHCO3 (10 mL) and
extracted with diethyl ether (3 × 10 mL). The organics were
combined, dried (Na2SO4) and evaporated in vacuo. The crude
material was purified by flash column chromatography.
3-Fluoro-6-phenyl-5,6-dihydro-1H-pyridin-2-one, 10a
α,β-Unsaturated lactam 9a (96 mg, 0.31 mmol) was subjected
to general procedure D using 0.45 g of ceric ammonium
nitrate (2.7 eq., 0.86 mmol). The crude product was purified by
flash column chromatography (0–30% EtOAc in petroleum
ether) to yield the desired dihydropyridone 10a (60 mg,
0.29 mmol, 94%) as a white solid. m.p. 109–111 °C.
1H (CDCl3, 400 MHz) δ: 7.45–7.37 (5H, m), 6.09 (1H, ddd,
JHF = 11.1 Hz, JHH = 5.9, 3.3 Hz), 5.62 (1H, br s), 4.82 (1H, dd,
JHH = 11.6, 5.8 Hz), 2.74–2.60 (2H, m).
19F (CDCl3, 470 MHz) δ:
−129.9. 13C (CDCl3, 125 MHz) δ: 161.2 (d, JCF = 32.8 Hz), 149.1
(d, JCF = 253.2 Hz), 139.9, 129.2 (2C), 128.8, 126.4 (2C), 113.5
(d, JCF = 13.8 Hz), 56.1, 31.2 (d, JCF = 5.0 Hz). m/z [EI (+ve)]
191.1 [M]+, HRMS found [M]+ 191.0748, C11H10FNO requires
191.0746. IR (thin film) νmax = 2356, 1705, 1670, 1248 cm
−1.
3-Fluoro-6-(4′-methoxyphenyl)-5,6-dihydro-1H-pyridin-2-one,
10b
α,β-Unsaturated lactam 9b (0.14 g, 0.42 mmol) was subjected
to general procedure D using 1.3 g of ceric ammonium nitrate
(5.5 eq., 2.3 mmol). The crude product was purified by flash
column chromatography (0–25% EtOAc in petroleum ether) to
yield the desired dihydropyridone 10b (37 mg, 0.17 mmol,
40%) as a yellow solid. m.p. 133–135 °C.
1H (CDCl3, 400 MHz) δ: 7.21 (2H, d, JHH = 8.6 Hz), 6.84 (2H,
d, JHH = 8.6 Hz), 6.01–6.97 (1H, m), 5.57 (1H, br s), 4.67 (1H,
dd, JHH = 12.1, 5.6 Hz,), 3.81 (3H, s), 2.60–2.46 (2H, m).
19F (CDCl3, 470 MHz) δ: −130.0. 13C (CDCl3, 125 MHz) δ: 161.1
(d, JCF = 31.3 Hz), 159.8, 149.8 (d, JCF = 253.8 Hz), 131.9, 127.6
(2C), 114.4 (2C), 113.6 (d, JCF = 13.8 Hz), 55.6, 55.4, 31.2
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(d, JCF = 5.3 Hz). m/z [CI (+ve)] 222.1 [M + H]
+, HRMS found
[M + H]+ 222.0929, C12H13FNO2 requires 222.09230. IR (thin
film) νmax = 1695, 1630, 1250 cm
−1.
3-Fluoro-6-(4′-trifluoromethanephenyl)-5,6-dihydro-1H-pyridin-
2-one, 10c
α,β-Unsaturated lactam 9c (0.16 g, 0.42 mmol) was subjected
to general procedure D using 1.1 g of ceric ammonium nitrate
(4.9 eq., 2.1 mmol). The crude product was purified by flash
column chromatography (0–20% EtOAc in petroleum ether) to
yield the desired dihydropyridone 10c (50 mg, 0.20 mmol,
47%) as a white solid. m.p. 104–105 °C.
1H (CDCl3, 500 MHz) δ: 7.60 (2H, d, JHH = 8.2 Hz), 7.43 (2H,
d, JHH = 8.2 Hz), 5.99 (1H, ddd, JHF = 11.8 Hz, JHH = 5.5,
3.6 Hz), 5.93 (1H, br s), 4.80 (1H, dd, JHH = 10.5, 6.1 Hz),
2.67–2.53 (2H, m). 19F (CDCl3, 470 MHz) δ: −62.4, −129.1.
13C (CDCl3, 125 MHz) δ: 161.1 (d, JCF = 31.3 Hz), 149.6 (d, JCF =
253.8 Hz), 144.0, 131.1, 130.9, 126.8 (2C), 126.1 (2C), 113.2
(d, JCF = 13.8 Hz), 55.4, 30.9 (d, JCF = 5.0 Hz). m/z [EI (+ve)]
259.1 [M]+, HRMS found [M]+ 259.0623, C12H9F4NO requires
259.0620. IR (thin film) νmax = 1720, 1705, 1680, 1305,
1180 cm−1.
3-Fluoro-6-(naphthalen-1′-yl)-5,6-dihydro-1H-pyridin-2-one,
10d
α,β-Unsaturated lactam 9d (0.11 g, 0.30 mmol) was subjected
to general procedure D using 0.97 g of ceric ammonium
nitrate (5.9 eq., 1.8 mmol). The crude product was purified by
flash column chromatography (0–15% EtOAc in petroleum
ether) to yield the desired dihydropyridone 10d (37 mg,
0.15 mmol, 51%) as a yellow solid. m.p. 135–137 °C.
1H (CDCl3, 400 MHz) δ: 7.96 (1H, d, JHH = 8.1 Hz), 7.85 (1H,
br d, JHH = 7.9 Hz), 7.79 (1H, d, JHH = 8.1 Hz), 7.55–7.41 (4H,
m), 6.04 (1H, dt, JHF = 11.0 Hz, JHH = 4.6 Hz), 5.74 (1H, br s),
5.56 (1H, t, JHH = 8.5 Hz), 2.81–2.76 (2H, m).
19F (CDCl3,
470 MHz) δ: −129.6. 13C (CDCl3, 125 MHz) δ: 161.2 (d, JCF =
33.0 Hz), 149.6 (d, JCF = 252.5 Hz), 135.3, 134.1, 130.0, 129.4,
129.2, 126.9, 126.2, 125.5, 123.9, 122.1, 113.7 (d, JCF = 12.5 Hz),
52.3, 29.7 (d, JCF = 5.0 Hz). m/z [EI (+ve)] 241.1 [M]
+, HRMS
found [M]+ 241.0902, C15H12FNO requires 241.0903. IR (thin
film) νmax = 1715, 1797, 1320, 1180 cm
−1.
3-Fluoro-6-(4′-bromophenyl)-5,6-dihydro-1H-pyridin-2-one, 10e
α,β-Unsaturated lactam 9e (0.19 g, 0.47 mmol) was subjected
to general procedure D using 0.98 g of ceric ammonium
nitrate (3.8 eq., 1.8 mmol). The crude product was purified by
flash column chromatography (0–20% EtOAc in petroleum
ether) to yield the desired dihydropyridone 10e (92 mg,
0.34 mmol, 72%) as a white solid. m.p. 199–200 °C.
1H (CDCl3, 400 MHz) δ: 7.56 (2H, d, JHH = 8.1 Hz), 7.27 (2H,
d, JHH = 8.1 Hz), 6.09 (1H, dt, JHF = 10.9 Hz, JH = 4.7 Hz), 5.58
(1H, br s), 4.79 (1H, t, JHH = 8.5 Hz), 2.67–2.62 (2H, m).
19F (CDCl3, 470 MHz) δ: −129.6. 13C (CDCl3, 125 MHz) δ: 161.0
(d, JCF = 31.2 Hz), 149.6 (d, JCF = 253.2 Hz), 138.9, 132.3 (2C),
128.0 (2C), 122.7, 113.3 (d, JCF = 13.8 Hz), 55.5, 31.0 (d, JCF =
5.0 Hz). m/z [CI (+ve)] 269.8 [M + H]+, HRMS found [M + H]+
269.9945, C11H10
79BrFNO requires 269.9930. IR (thin film)
νmax = 1705, 1685, 1205, 1010 cm
−1.
3-Fluoro-6-isobutyl-5,6-dihydro-1H-pyridin-2-one, 10f
α,β-Unsaturated lactam 9f (0.13 g, 0.44 mmol) was subjected to
general procedure D using 0.91 g of ceric ammonium nitrate
(3.8 eq., 1.7 mmol). The crude product was purified by flash
column chromatography (0–10% EtOAc in petroleum ether) to
yield the desired dihydropyridone 10f (70 mg, 0.4 mmol, 92%)
as a white solid. m.p. 61–63 °C.
1H (CDCl3, 500 MHz) δ: 6.07 (1H, ddd, JHF = 11.1 Hz, JHH =
5.9, 3.3 Hz), 5.59 (1H, br s, NH), 3.76–3.72 (1H, m), 2.49–2.40
(1H, m), 2.34–2.25 (1H, m), 1.74–1.63 (1H, m), 1.59–1.51 (1H,
m), 1.45–1.36 (1H, m), 0.97 (3H, d, JHH = 6.6 Hz), 0.96 (3H, d,
JHH = 6.6 Hz).
19F (CDCl3, 470 MHz) δ: −130.1. 13C (CDCl3,
100 MHz) δ: 161.2 (d, JCF = 28.0 Hz), 149.7 (d, JCF = 253.0 Hz),
113.7 (d, JCF = 13.0 Hz), 49.3, 44.0, 28.3 (d, JCF = 5.0 Hz), 24.4,
22.6, 22.2. m/z [CI (+ve)] 172.1 [M + H]+, HRMS found [M + H]+
172.1144, C9H15FNO requires 172.1138. IR (thin film) νmax =
3219, 2934, 2906, 1696, 1669, 1264, 1206 cm−1.
3-Fluoro-6-cyclohexane-5,6-dihydro-1H-pyridin-2-one, 10g
α,β-Unsaturated lactam 9g (0.22 g, 0.70 mmol) was subjected
to general procedure D using 1.3 g of ceric ammonium nitrate
(3.3 eq., 2.3 mmol). The crude product was purified by flash
column chromatography (0–10% EtOAc in petroleum ether) to
yield the desired dihydropyridone 10g (0.11 g, 0.55 mmol,
79%) as a white solid. m.p. 108–110 °C.
1H (CDCl3, 400 MHz) δ: 5.98 (1H, dt, JHF = 11.4 Hz, JHH =
4.3 Hz), 5.54 (1H, br s), 3.35 (1H, br q, JHH = 7.7 Hz), 2.32–2.29
(2H, m), 1.74–1.61 (5H, m), 1.43–1.32 (1H, m), 1.19–0.97 (3H,
m), 0.95–0.92 (2H, m). 19F (CDCl3, 470 MHz) δ: −130.5. 13C
(CDCl3, 125 MHz) δ: 161.3 (d, JCF = 31.3 Hz), 149.6 (d, JCF =
252.5 Hz), 114.0 (d, JCF = 13.8 Hz), 56.0, 41.4, 28.8, 28.7, 26.1,
25.9 (d, JCF = 5.0 Hz), 24.9, 24.8. m/z [CI (+ve)] 198.1 [M + H]
+,
HRMS found [M + H]+ 198.1295, C11H17FNO requires 198.1294.
IR (thin film) νmax = 2927, 2855, 1691, 1652, 1208, 1199 cm
−1.
General procedure E: hydrogenation of α,β-unsaturated
lactams
A solution of dihydropyridone (1 eq.) in MeOH (2 mL) was
treated with palladium activated charcoal (10% by weight) and
the suspension was stirred under a H2 atmosphere until com-
pletion indicated by TLC analysis (1–4 hours). The resulting
mixture was filtered through celite, dried (Na2SO4) and the
solvent was removed under reduced pressure. The crude
product was purified by flash column chromatography.
3-Fluoro-6-phenyl-piperidin-2-one, 11a
Dihydropyridone 10a (43 mg, 0.22 mmol) was subjected to
general procedure E. The crude product was purified by flash
column chromatography (0–30% EtOAc in petroleum ether) to
yield the desired δ-lactam 11a (32 mg, 0.17 mmol, 75%) as a
white solid. m.p. 149–151 °C.
1H (CDCl3, 400 MHz) δ: 7.45–7.32 (5H, m), 5.93 (1H, br s),
4.95 (1H, dt, JHF = 46.27 Hz, JHH = 5.28 Hz), 4.61–4.60 (1H, m),
Paper Organic & Biomolecular Chemistry
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2.28–2.24 (1H, m), 2.17–2.03 (3H, m). 19F (CDCl3, 470 MHz) δ:
−180.3. 13C (CDCl3, 125 MHz) δ: 167.5 (d, JCF = 20.1 Hz), 141.4,
129.0 (2C), 128.4, 126 1 (2C), 85.7 (d, JCF = 175.1 Hz), 57.3, 27.3
(d, JCF = 3.7 Hz), 26.2 (d, JCF = 20.0 Hz). m/z [EI (+ve)] 193.1 [M]
+.
HRMS found [M]+ 193.0904, C11H12FNO requires 193.0903. IR
(thin film) νmax = 3194, 2066, 2958, 1666, 1329 cm
−1.
3-Fluoro-6-(4′-methoxyphenyl)-piperidin-2-one, 11b
Dihydropyridone 10b (24 mg, 0.11 mmol) was subjected to
general procedure E. The crude product was purified by flash
column chromatography (0–50% EtOAc in petroleum ether) to
yield the desired δ-lactam 11b (14 mg, 0.06 mmol, 58%) as a
white solid. m.p. 159–161 °C.
1H (CDCl3, 400 MHz) δ: 7.25 (2H, d, JHH = 8.6 Hz), 6.94 (2H,
d, JHH = 8.6 Hz), 5.83 (1H, s), 4.94 (1H, dt, JHF = 47.1 Hz, JHH =
4.6 Hz), 4.56–4.51 (1H, m), 3.84 (3H, s), 2.34–2.24 (1H, m),
2.13–1.96 (3H, m). 19F (CDCl3, 470 MHz) δ: −184.8. 13C (CDCl3,
125 MHz) δ: 167.2 (d, JCF = 22.1 Hz), 159.6, 133.4, 127.3 (2C),
114.4 (2C), 85.7 (d, JCF = 176.1 Hz), 57.0, 55.4, 27.4 (d, JCF =
4.6 Hz), 26.4 (d, JCF = 21.2 Hz). m/z [EI (+ve)] 223.1 [M]
+. HRMS
found [M]+ 223.0999, C12H14FNO2 requires 223.1009. IR (thin
film) νmax = 2930, 1695, 1510, 1230 cm
−1.
3-Fluoro-6-(4′-trifluoromethanephenyl)-piperidin-2-one, 11c
Dihydropyridone 10c (29 mg, 0.11 mmol) was subjected to
general procedure E. The crude product was purified by flash
column chromatography (0–40% EtOAc in petroleum ether) to
yield the desired δ-lactam 11c (29 mg, 0.11 mmol, quantitative
yield) as a white solid. m.p. 122–124 °C.
1H (CDCl3, 400 MHz) δ: 7.60 (2H, d, JHH = 8.2 Hz), 7.38 (2H,
d, JHH = 8.2 Hz), 5.93 (1H, s), 4.86 (1H, dt, JHF = 47.1 Hz, JHH =
5.0 Hz), 4.59 (1H, br t, JHH = 5.7 Hz), 2.22–2.12 (1H, m),
2.11–1.89 (3H, m). 19F (CDCl3, 470 MHz) δ: −62.4, −185.0.
13C (CDCl3, 125 MHz) δ: 167.4 (d, JCF = 22.3 Hz), 145.4, 130.9,
130.6, 126.6 (2C), 126.1 (2C), 85.5 (d, JCF = 176.5 Hz), 57.0, 27.2
(d, JCF = 4.2 Hz), 26.1 (d, JCF = 21.0 Hz). m/z [EI (+ve)] 261.1 [M]
+.
HRMS found [M]+ 261.0773, C12H11F4NO requires 261.0777.
IR (thin film) νmax = 3005, 2970, 1675, 1430 cm
−1.
3-Fluoro-6-(naphthalen-1′-yl)-piperidin-2-one, 11d
Dihydropyridone 10d (38 mg, 0.15 mmol) was subjected to
general procedure E. The crude product was purified by flash
column chromatography (0–40% EtOAc in petroleum ether) to
yield the desired δ-lactam 11d (29 mg, 0.12 mmol, 81%) as a
white solid. m.p. 144–147 °C.
1H (CDCl3, 400 MHz) δ: 7.99–7.93 (2H, m), 7.87 (1H, d,
JHH = 8.0 Hz), 7.62–7.51 (4H, m), 6.02 (1H, s), 5.48–5.46 (1H,
m), 5.02 (1H, dt, JHF = 46.9 Hz, JHH = 5.7 Hz), 2.43–2.33 (1H,
m), 2.28–2.23 (3H, m). 19F (CDCl3, 377 MHz) δ: −186.1.
13C (CDCl3, 100 MHz) δ: 168.3 (d, JCF = 19.9 Hz), 136.6, 134.0,
129.8, 129.4, 128.9, 126.8, 126.0, 125.4, 123.7, 121.9, 85.8
(d, JCF = 177.0 Hz), 53.3, 25.9 (d, JCF = 6.0 Hz), 25.7 (d, JCF =
20.0 Hz). m/z [CI (+ve)] 244.0 [M + H]+, HRMS found [M + H]+
244.1137, C15H15FNO requires 244.1138. IR (thin film) νmax =
3240, 2900, 1650, 1110 cm−1.
3-Fluoro-6-isobutyl-piperidin-2-one, 11f
Dihydropyridone 10f (39 mg, 0.23 mmol) was subjected to
general procedure E. The crude product was purified by flash
column chromatography (0–20% EtOAc in petroleum ether) to
yield the desired δ-lactam 11f (40 mg, 0.23 mmol, quantitative
yield) as a white solid. m.p. 78–81 °C.
1H (CDCl3, 400 MHz) δ: 6.00 (1H, s), 4.80 (1H, dt, JHF =
48.6 Hz, JHH = 4.5 Hz), 3.40–3.37 (1H, m), 2.16–2.13 (1H, m),
1.96–1.89 (1H, m), 1.81–1.77 (1H, m), 1.64–1.58 (2H, m),
1.40–1.31 (2H, m), 0.87 (3H, d, JHH = 6.6 Hz), 0.85 (3H, d, JHH =
6.6 Hz). 19F (CDCl3, 470 MHz) δ: −185.0. 13C (CDCl3, 125 MHz)
δ: 167.4 (d, JCF = 20.0 Hz), 86.3 (d, JCF = 173.8 Hz), 50.8, 45.6,
26.5 (d, JCF = 21.3 Hz), 24.3, 24.0 (d, JCF = 3.7 Hz), 22.6, 22.3.
m/z [CI (+ve)] 174.1 [M + H]+, HRMS found [M + H]+ 174.1300,
C9H17FNO requires 174.1294. IR (thin film) νmax = 2950, 2935,
1630 cm−1.
3-Fluoro-6-cyclohexane-piperidin-2-one, 11g
Dihydropyridone 10g (80 mg, 0.40 mmol) was subjected to
general procedure E. The crude product was purified by flash
column chromatography (0–20% EtOAc in petroleum ether) to
yield the desired δ-lactam 11g (81 mg, 0.40 mmol, quantitative
yield) as a white solid. m.p. 148–159 °C.
1H (CDCl3, 500 MHz) δ: 5.93 (1H, s), 4.74 (1H, dt, JHF = 47.2
Hz, JHH = 4.4 Hz), 3.13–3.09 (1H, m), 2.21–2.13 (1H, m),
1.90–1.79 (1H, m), 1.74–1.62 (7H, m), 1.35–1.30 (1H, m),
1.22–1.14 (2H, m), 1.11–1.03 (1H, m), 0.99–0.89 (2H, m).
19F (CDCl3, 470 MHz) δ: −184.6. 13C (CDCl3, 125 MHz) δ: 167.4
(d, JCF = 19.9 Hz), 86.0 (d, JCF = 173.7 Hz), 57.8, 42.6, 28.6, 28.4,
26.9 (d, JCF = 21.3 Hz), 26.2, 26.0, 25.9, 20.2 (d, JCF = 3.4 Hz).
m/z [EI (+ve)] 199.1 [M]+. HRMS found [M]+ 199.1376,
C11H18FNO requires 199.1372. IR (thin film) νmax = 2926, 2870,
1664, 1410 cm−1.
3-Fluoro-6-(4′-phenylphenyl)-5,6-dihydro-1H-pyridin-2-one, 12
Dihydropyridone 10e (98 mg, 0.36 mmol) was dissolved in a
mixture of toluene (12 mL) and H2O (2 mL). K2CO3 (0.11 g,
0.79 mmol), PhB(OH)2 (88 mg, 0.72 mmol) and Pd(PPh3)4
(84 mg, 20 mol%) were then sequentially added and the result-
ing solution was heated at 90 °C for 16 h. The reaction was
cooled down to room temperature and was filtered through
celite and the celite was washed with EtOAc (30 mL). The
organic layer was washed with H2O (1 × 10 mL) and brine
(1 × 10 mL) and then dried (Na2SO4) and evaporated in vacuo.
The crude residue was purified by flash column chromato-
graphy (0–20% EtOAc in petroleum ether) to yield the desired
cross-coupled product 12 (87 mg, 0.33 mmol, 90%) as a white
solid. m.p. 199–201 °C.
1H NMR (CDCl3, 400 MHz) δ: 7.58 (2H, d, JHH = 8.0 Hz),
7.52 (2H, d, JHH = 8.0 Hz), 7.40–7.31 (5H, m), 6.02 (1H, ddd,
JHH = 11.0, 5.8, 3.3 Hz), 5.59 (1H, s), 4.77 (1H, dd, JHH = 11.3,
6.0 Hz), 2.70–2.55 (2H, m). 19F (CDCl3, 377 MHz) δ: −129.8.
13C (CDCl3, 100 MHz) δ: 161.0 (d, JCF = 31.1 Hz), 149.9
(d, JCF = 253.6 Hz), 141.8, 140.2, 138.9, 128.9 (2C), 127.8 (2C),
127.7, 127.1 (2C), 126.8 (2C), 113.5 (d, JCF = 14.0 Hz), 55.8, 31.1
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(d, JCF = 5.7 Hz). m/z [EI (+ve)] 267.1 [M]
+, HRMS found [M]+
267.1058, C17H14FNO requires 267.1059. IR (thin film) νmax =
2358, 1693, 1658, 1258, 1198 cm−1.
3-Fluoro-6-(4′-phenylphenyl)-piperidin-2-one, 13
Dihydropyridone 12 (34 mg, 0.13 mmol) was subjected to
general procedure E. The crude product was purified by flash
column chromatography (0–40% EtOAc in petroleum ether) to
yield the desired δ-lactam 13 (34 mg, 0.13 mmol, quantitative)
as a white solid. m.p. 171–173 °C.
1H (CDCl3, 400 MHz) δ: 7.64 (2H, d, JHH = 7.5 Hz), 7.61 (2H,
d, JHH = 7.5 Hz), 7.50–7.38 (5H, m), 5.91 (1H, s), 4.97 (1H, dt,
JHF = 43.7 Hz, JHH = 4.5 Hz), 4.67–4.63 (1H, m), 2.36–2.27 (1H,
m), 2.20–2.04 (3H, m). 19F (CDCl3, 377 MHz) δ: −185.1.
13C (CDCl3, 100 MHz) δ: 167.5 (d, JCF = 19.8 Hz), 141.4, 140.3,
140.2, 128.9 (2C), 127.7 (2C), 127.6, 127.1 (2C), 126.6 (2C), 85.7
(d, JCF = 176.0 Hz), 57.2, 27.3 (d, JCF = 4.0 Hz), 26.3 (d, JCF =
21.0 Hz). m/z [EI (+ve)] 269.0 [M]+, HRMS found [M]+ 269.1214,
C17H16FNO requires 269.1216. IR (thin film) νmax = 3239, 2949,
2356, 1676, 1486 cm−1.
Crystallographic data collection and refinement details
X-ray diﬀraction data of crystals of 11a were collected at 150 K
on an Oxford Diﬀraction Gemini CCD diﬀractometer equipped
with an Oxford Cryosystems Cryostream low-temperature
device and using graphite monochromated Cu Kα radiation
(λ = 1.54184 Å). Data reduction was carried out and an ana-
lytical numeric absorption correction was applied [based on
expressions derived in R. C. Clark and J. S. Reid, Acta
Crystallogr., Sect. A: Fundam. Crystallogr., 1995, 51, 887–897]
using the CrysAlisPro [Oxford Diﬀraction Limited., Version
1.171.33.55, Oxfordshire, UK]. The structures were all solved
by direct methods using the program SHELXS97 [SHELX,
G. M. Sheldrick, Acta Crystallogr., Sect. A: Fundam. Crystal-
logr., 2008, 64, 112–122] and refined using full-matrix least-
squares refinement on F2 using SHELXL97 [SHELX,
G. M. Sheldrick, Acta Crystallogr., Sect. A: Fundam. Crystal-
logr., 2008, 64, 112–122] within the WinGX program suite
[L. J. Farrugia, J. Appl. Crystallogr., 1999, 32, 837–838]. The
Flack x parameter [H. D. Flack, Acta Crystallogr., Sect. A:
Fundam. Crystallogr., 1983, 39, 876.] was determined for 11a.
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